Guest guest Posted May 26, 2004 Report Share Posted May 26, 2004 From Journal of Gastroenterology & Hepatology Barrett's Esophagus: Prevalence and its Relationship With Dyspeptic Symptoms Posted 05/17/2004 Murat Toruner; Irfan Soykan; Arzu Ensari; Isinsu Kuzu; Cihan Yurdaydin; Ali Özden Abstract and Introduction Abstract Background and Aim: Barrett's metaplasia is a premalign condition which plays a pivotal role in the development of esophageal adenocarcinoma. It is considered a complication of chronic gastroesophageal reflux disease. Although esophageal adenocarcinoma is an uncommon cancer, its incidence is rapidly increasing. The aims of the present study were to determine the prevalence of Barrett's metaplasia in outpatients referred for gastroscopy for upper gastrointestinal symptoms, and to clarify the relationship between Barrett's metaplasia and upper gastrointestinal symptoms. Methods: Three-hundred and ninety-five consecutive dyspeptic patients, never previously investigated, underwent gastroscopy and were enrolled into the study. Results: Barrett's metaplasia was detected in 29 patients (7.4%). The age-specific prevalence of Barrett's metaplasia increased with age. In multivariate analysis, Barrett's metaplasia was independently and positively related to age, sex and duration of symptoms, but not with upper gastrointestinal symptoms. In univariate analysis, Barrett's metaplasia was significantly more common in patients with antral intestinal metaplasia (24%) and presence of hiatal hernia (65.5%), compared with those with normal endoscopic findings (6.2% and 39.2%, respectively, p = 0.001). Conclusion: Symptoms do not predict Barrett's metaplasia. Barrett's metaplasia is age-related and more common in patients with a longer duration of symptoms, presence of hiatal hernia and antral intestinal metaplasia. Introduction Barrett's esophagus (BE) is a metaplastic change of the lining of the esophagus with replacement of the normal squamous epithelium with columnar epithelium containing goblet cells. It is the most severe histological consequence of chronic gastroesophageal reflux and predisposes to the development of adenocarcinoma of the esophagus.[1,2] As increases in the incidence of esophageal adenocarcinoma have been reported in Western countries such as the USA, New Zealand, Australia and western European countries in recent years,[3-6] interest in the prevalence of BE and its predicting factors has increased. Barrett's esophagus is usually discovered during endoscopic examination of middle-aged and older adults whose mean age at the time of diagnosis is approximately 55 years.[7] Series of surgical resections of adenocarcinoma of the esophagus associated with BE reveal that it is overwhelmingly predominate in white males.[8,9] The columnar metaplasia in BE causes no symptoms. Thus, patients are seen initially for symptoms of the associated gastroesophageal reflux disease (GERD), such as heartburn and regurgitation. Endoscopically obvious BE can be seen in approximately 10% of patients who have endoscopic examinations for symptoms of GERD. However, approximately 25% of patients have no esophageal symptoms.[10] Additionally, there are data suggesting that the duration of reflux symptoms significantly correlates with the prevalence of BE.[11,12] In this setting, BE is discovered during endoscopic examinations performed for unrelated conditions. The epidemiology of BE is incompletely described. In recent years, by definition of short segment Barrett's esophagus (SSBE), an increase in the prevalence of BE has been detected. In a study from the USA, BE was detected in 25% of asymptomatic male veterans older than 50 years undergoing screening sigmoidoscopy for colorectal cancer.[13] In another study from Japan, BE was detected in 15.7% of individuals who underwent an upper gastrointestinal endoscopy for the evaluation of BE.[14] The aims of the present study were to investigate the prevalence of BE in a group of patients who had undergone gastroscopy due to dyspeptic symptoms, and to determine the relationship between BE and these symptoms. Methods The study population consisted of patients who were referred to the endoscopy unit between March and July 2001. A total of 395 patients who were admitted to the endoscopy unit were enrolled into the study. Patients who had esophageal or gastric cancer, previous esophageal or gastric surgery, gastrointestinal bleeding at the time of endoscopy, or coagulation defects were excluded from the study. All patients entering the study were asked to complete a symptom questionnaire concerning the presence of heartburn, regurgitation, epigastric pain, nausea and vomiting. All endoscopic examinations were performed by one of the investigators (MT) using a standard video upper endoscope (Fujinon EG-410 HR, Tokyo, Japan). During endoscopic examination, the appearance of the esophagogastric junction was carefully inspected (EGJ; defined as the junction of the proximal gastric folds and the tubular esophagus). The squamocolumnar junction was also identified as the point where the squamous mucosa joined the salmon-color columnar mucosa. All patients were classified as having either a normal appearing EGJ, a long-segment BE (LSBE; defined as the presence of intestinal metaplasia extending proximally from the EGJ and measuring 3 cm or more in length), or a short-segment BE (SSBE; defined as segments of intestinal metaplasia emanating from the EGJ and measuring less than 3 cm). The diagnosis of specialized intestinal metaplasia of the esophagogastric junction (SIM-EGJ) was defined by the presence of a normal appearing squamocolumnar junction, devoid of any tongues of pink columnar lined epithelium above the endoscopically defined EGJ, but associated with specialized intestinal metaplasia containing goblet cells on biopsy specimens. Cardiac type metaplasia was defined as columnar metaplasia with glands containing mucous cells.[13,15,16] Hiatal hernia was diagnosed when the length between the EGJ and diaphragmatic pinch was >2 cm. At endoscopy, esophagitis, if present, was noted and graded according to the Los Angeles classification as follows: grade A, one (or more) mucosal break no longer than 5 mm that does not extend between the tops of two mucosal folds; grade B, one (or more) mucosal break more than 5 mm long that does not extend between the tops of two mucosal folds; grade C, one (or more) mucosal break that is continuous between the tops of two or more mucosal folds but which involves less than 75% of the circumference; grade D, one (or more) mucosal break which involves at least 75% of the esophageal circumference.[17] The following additional data were gathered for each patient: age; sex; alcohol (current alcohol users); tobacco (current cigarette smokers); medication use and; histological findings in the antrum, including presence of Helicobacter pylori infection. When a normal appearing EGJ was encountered, at least six mucosal biopsy specimens were taken for histological assessment. Four biopsy specimens were obtained from the squamocolumnar junction, with one cup of the biopsy forceps positioned on squamous epithelium, and the other cup on the columnar epithelium. Two were acquired from the gastric antrum. If BE was suspected, additional biopsy specimens were obtained to sample any mucosal tongues of glandular epithelium arising from the EGJ. These biopsy specimens were obtained from all possible quadrants and at every 1 cm up the length of the columnar epithelium. All biopsy specimens were immediately submerged in a 10% formalin solution and later stained with hematoxylin and eosin and with Alcian blue staining at a pH of 2.5. The evaluation of these biopsy specimens was performed by two qualified pathologists (AE and IK). The present study was approved by the Institutional Review Board of Ankara University Medical School and all patients signed informed consent forms beforehand. Statistical Analysis Analysis was performed using the SPSS software package, version 7.5.2 (SPSS, Chicago, IL, USA). The chi-squared test was used to compare categorical data. Continuous variables were analyzed using Student's t-test. To test for a potential relationship between BE and upper gastrointestinal symptoms, logistic regression analysis was performed with SPSS. The level of significance was set at p < 0.05. Results Median age of the patients enrolled in the study (n= 395, 224 women) was 47 years (range: 19-48 years). Demographic and clinical characteristics of patients are shown in Table 1. Gastrointestinal symptoms such as heartburn, epigastric pain, vomiting and nausea were seen predominantly in female patients. Smoking and alcohol consumption were observed more frequently in male patients. Symptom duration did not differ between the sexes. Helicobacter pylori positivity was 62.5% and there was no difference between males (63.1%) and females (62.1%). Endoscopic findings from the patients are described in Table 2. Endoscopic examination revealed squamocolumnar junction (SCJ) irregularity and/or Barrett's segments, islands and tongues in 129 patients (32.7%), predominantly in males (38.1%vs 28.6% females). Endoscopic esophagitis was observed in 61 (15.4%) patients (36 grade A and 25 grade . Esophagitis was detected more frequently in male patients (male 38 [22.2%]vs female 23 [10.3%]; p < 0.05). Hiatus hernia frequency did not differ between the sexes (male 77 [45.6%]vs female 81 [36.6%]; p = not significant [NS]). Barrett's metaplasia was histologically confirmed in 29 (7.4%) patients (14.8% of patients with irregular Z-line and Barrett's tongues, 27.7% of patients with Barrett's islands and 71.4% of patients with long segment Barrett's epithelium were confirmed histologically). Two of these 29 Barrett's metaplasia patients were diagnosed as having low-grade dysplasia. After histopathological examination of the biopsy specimens, patients enrolled into the study were divided into four groups: normal (n = 306, 77.6%); cardiac type metaplasia (CM; n = 31, 7.9%); specialized intestinal metaplasia at squamocolumnar junction (SIM-SCJ; n = 28, 7.1%) and; Barrett's metaplasia (BM; n = 29, 7.4%). Patients with BM were more likely to be male (55.2%vs 44.8% females), whereas patients in the normal (43.8%, n = 134 vs 56.2%, n = 172), CM (29%, n = 9 vs 71%, n = 22) and SIM-SCJ (42.9%, n = 12 vs 57.1%, n = 16) groups were predominantly female. The distribution of H. pylori infection in each group according to sex was as follows: CM, H. pylori (+) n = 22 (14 women), H. pylori (-) n = 9 (7 women); SIM-SCJ, H. pylori (+) n = 16 (9 women), H. pylori (-) n = 12 (7 women) (P = NS). Although gastrointestinal symptoms such as heartburn, epigastric pain, vomiting and nausea were seen more frequently in female patients and male patients had more social habits such as smoking and alcohol consumption, there was no significant difference between these four groups. Symptom duration was longer in the BM group than in the other three groups (normal, CM and SIM-SCJ; 92 [2-360]vs 36 [0.2-480] and 48 [1-360] months, respectively, p < 0.05). Hiatal hernia was seen more frequently in the BM group than in the other three groups (normal, CM and SIM-SCJ; 65.5%vs 39.2%, 35.5% and 30.8, respectively [P< 0.05]). Hiatus hernia was found in 65.5% (19/29) of patients with BE and only 35.2% (129/366) of patients without BE (P< 0.01). Intestinal metaplasia in the antrum was observed more in the CM, SIM-SCJ and BM groups than in the normal group (32.3%, 17.9%, 24.1%vs 6.2%, respectively, p < 0.05). Helicobacter pylori positivity did not differ with presence of Barrett's metaplasia and endoscopic esophagitis. Clinical and endoscopic characteristics of the patients are summarized in Table 3. Regarding age, the incidence of Barrett's metaplasia increased with age (Fig. 1). Discussion Barrett's metaplasia has been accepted as a premalign lesion of the esophagus which can lead to the development of adenocarcinoma of the esophagus. Therefore, investigations in this area have increased in recent years. However, little is known about its epidemiology and the predictors of BE. In the present study, we found that 7.4% of patients who had undergone upper gastrointestinal (GI) endoscopy for different reasons had Barrett's metaplasia. Differences between the reported prevalence of BE have been observed among studies from different countries. In Germany, prevalence of BE was reported to be 4.2%.[18] In Japan, where esophageal adenocarcinoma is accounting for <5% of esophageal cancers, BE prevalence is 0.3-0.6%. As esophageal adenocarcinoma is increasing worldwide, in Turkey the ratio of esophageal cancer is 19.2% among all GI cancers, which is higher than that seen in other Balkan countries. The majority of patients, especially in eastern regions of Turkey, have squamous cell esophageal carcinoma because of the common consumption of hot beverages in this region. Esophageal adenocarcinoma accounts for approximately 10% of esophageal cancers in Turkey.[19] Adenocarcinoma of the esophagus and BE are not common in Africa and the Middle-East. However, BM prevalence was reported to be 8.4% in Jordan.[18] In another study from Turkey, Dincer et al. reported a very low prevalence (1.7%) of BE in their study population. Although the number of patients studied was quite small (n = 60), they concluded that this finding may be related to the relatively younger mean age of patients.[20] We also found that BE is seen predominantly in older age groups and males. These results are in agreement with previous studies that reported a higher prevalence in older groups of patients and males.[21] Although 57% of our patients were female, this difference did not reach statistical significance. Vontilainen et al. found that the male to female ratio of BE patients was 1.[22] Hirota et al. have also reported an equal distribution of BE between males and females.[23] The diagnosis of SSBE can be missed if endoscopic landmarks are not carefully determined and there is lack of targeting of biopsy samples. A recent study by Padda et al. showed that histological confirmation of SSBE and LSBE was 38.4% and 75%, respectively.[24] Our results for LSBE were similar but we found a lower confirmation rate for SSBE. The sensitivity and positive predictive values of standard upper endoscopy for diagnosing BE have been reported as 82% and 34%, respectively.[25] This may be secondary to the patchy and mosaic presence of intestinal metaplasia in the distal esophagus. Hiatus hernia is known to be more common in patients with Barrett's metaplasia than in healthy controls. A recent study by Cameron demonstrated that 96% of his patients with BE harbored a hiatus hernia.[26] Additionally, the hiatus sac tended to be longer and wider in patients with BE. In our study, hiatus hernia was found in 65.6% (n = 19) of patients with BE and in only 35.2% (n = 129) of patients without BE (P < 0.01). It has been known that hiatus hernia presence may lead to GERD which can cause BE.[27] Although esophagitis is one of the important factors in the development of BE, in our study the rate of endoscopic esophagitis was almost the same between patients with BE and the normal group. Results of previous studies investigating the association between esophagitis and BE are controversial. While some previous studies found no correlation between esophagitis and BE,[28,29] Voutilainen et al. demonstrated that junctional specialized columnar epithelium was associated with erosive esophagitis, suggesting that specialized columnar epithelium may be a result of GERD.[23] In our study, we found no association between BE presence with gastroesophageal reflux and/or other dyspeptic symptoms. In most of the published studies there are some controversial reports discussing this possible association. Spechler et al. and Nandurkar et al. showed that the prevalence of the SSBE has not been linked with gastroesophageal reflux symptoms.[29,30] However, Pereira et al. and ston et al. found an association between prevalence of SSBE and gastroesophageal reflux symptoms.[31,32] The possible reason for lack of this kind of association in our study may be a result of the small number of LSBE in our study population. However, we found a significant correlation between the symptom duration and the presence of BE, which demonstrates the longer duration of acid/bile reflux to esophagus is a risk factor for developing BE. The role of H. pylori infection in BE development is still controversial. Some investigators have reported that H. pylori infection plays a protective role in GERD and BE development.[33] This protective role is explained by reduced gastric acid secretion after H. pylori infection. Some recent reports have indicated that not all H. pylori infections, but infections with Cag A positive strains, protect against GERD. However, there are some reports indicating no relationship between H. pylori infection and BE prevalence.[34-36] We found a lower incidence of H. pylori infection in patients with esophagitis than without esophagitis, but this difference did not reach any significance. In our study there was no correlation between H. pylori infection and BE prevalence. Hackelsberger et al. found that in patients with endoscopic features suggestive or typical of BE, 34.3% had intestinal metaplasia at the SCJ which was associated with male sex, esophagitis and reflux symptoms, but not with H. pylori or gastric intestinal metaplasia.[37] Conversely, Oberg et al. investigated 229 patients with symptoms suggestive of foregut disease by means of esophageal manometry, 24-h pH monitoring and upper gastrointestinal endoscopy with biopsy specimens obtained from the gastric antrum, the GEJ and the distal esophagus. They concluded that H. pylori plays no role in the pathogenesis of GERD or its complications.[38] In our study, the rate of antral intestinal metaplasia in the BE group was higher than that in the normal group. However, antral H. pylori infection in the BE group and normal group was almost the same. This discrepancy between the two groups suggests that there are some factors other than H. pylori infection, such as long standing chronic gastritis (autoimmune, type A chronic atrophic gastritis) and probably other environmental factors that affect the development of intestinal metaplasia.[39] In conclusion, all patients with GERD/dyspeptic symptoms and a longer duration of symptoms should undergo upper gastrointestinal endoscopy for screening of BE, and those with observed hiatus hernia should be investigated for the presence of BE. We believe that the present study will shed new light on the epidemiology and geoprevalence of BE around the world. Dr Murat Toruner, Ankara University Medical School, Ibni Sina Hospital, Division of Gastroenterology, Sihhiye, 06100, Ankara, Turkey. Email: toruner@... Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.